Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

First phase of enrollment of single device for CCM \u00ae and ICD therapy complete \n “,”tablet”:” Continued Progress Earns Financing to Accelerate Commercial Growth and Advancing Pipeline “} },”slug”:”et_pb_text”}” data-et-multi-view-load-tablet-hidden=”true”> First phase of enrollment of single device for CCM ® and ICD therapy complete MARLTON, N.J., April 28, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics ® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it reached an important milestone in the INTEGRA-D ™ clinical